• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血友病患者体内高纯度凝血因子VIII的回收率较低。

Low recovery in vivo of highly purified factor VIII in patients with hemophilia.

作者信息

Manno C S, Butler R B, Cohen A R

机构信息

Division of Hematology, Children's Hospital of Philadelphia, PA 19104.

出版信息

J Pediatr. 1992 Nov;121(5 Pt 1):814-8. doi: 10.1016/s0022-3476(05)81921-3.

DOI:10.1016/s0022-3476(05)81921-3
PMID:1432437
Abstract

To assess whether the response and recovery of highly purified factor VIII products approach the levels predicted by use of manufacturers' suggestions, we studied response in vivo and percentage of recovery in boys and men with hemophilia after infusion of 50 IU of an immunoaffinity-purified factor VIII preparation (Hemofil M) per kilogram of body weight. We also studied dose response and percentage of recovery in the same boys after infusion of a factor VII concentrate prepared by solvent detergent treatment and gel filtration (Koate-HP). For boys the difference between mean peak factor VIII response with Hemofil M (1.02% +/- 0.07%) and the response with Koate-HP (1.21% +/- 0.10%) was not significant (p = 0.10), but the response of both products was considerably less than the predicted response of 2.0%. The response to Hemofil M in men (1.38% +/- 0.12%) was significantly better than the response in boys (p = 0.004) but, again, fell short of the anticipated response of 2.0%. In boys the percentage of recovery of Hemofil M was 38.4% +/- 2.1%, compared with Koate-HP recovery, which was 47.0% +/- 3.6% (p = 0.034). The percentage of recovery in men was 47.5% +/- 2.8%. The better response observed in men appears to be, in part, a function of larger body size. We conclude that peak factor VIII response and recovery in boys and men who receive highly purified factor VIII concentrates are lower than those predicted by use of current prescribing recommendations.

摘要

为评估高度纯化的凝血因子VIII产品的反应及恢复情况是否接近按照制造商建议所预测的水平,我们研究了血友病男孩和男性在每千克体重输注50国际单位免疫亲和纯化的凝血因子VIII制剂(Hemofil M)后的体内反应及恢复百分比。我们还研究了同一批男孩在输注经溶剂去污剂处理和凝胶过滤制备的凝血因子VII浓缩剂(Koate-HP)后的剂量反应及恢复百分比。对于男孩而言,Hemofil M的平均凝血因子VIII峰值反应(1.02%±0.07%)与Koate-HP的反应(1.21%±0.10%)之间的差异不显著(p = 0.10),但两种产品的反应均明显低于预测的2.0%的反应。男性对Hemofil M的反应(1.38%±0.12%)显著优于男孩(p = 0.004),但同样未达到预期的2.0%的反应。在男孩中,Hemofil M的恢复百分比为38.4%±2.1%,而Koate-HP的恢复百分比为47.0%±3.6%(p = 0.034)。男性的恢复百分比为47.5%±2.8%。在男性中观察到的更好反应似乎部分是由于体型较大。我们得出结论,接受高度纯化凝血因子VIII浓缩剂的男孩和男性的凝血因子VIII峰值反应及恢复低于按照当前处方建议所预测的水平。

相似文献

1
Low recovery in vivo of highly purified factor VIII in patients with hemophilia.血友病患者体内高纯度凝血因子VIII的回收率较低。
J Pediatr. 1992 Nov;121(5 Pt 1):814-8. doi: 10.1016/s0022-3476(05)81921-3.
2
Superior in vivo response of recombinant factor VIII concentrate in children with hemophilia A.重组凝血因子VIII浓缩物在甲型血友病儿童体内的反应更佳。
J Pediatr. 1997 Apr;130(4):537-40. doi: 10.1016/s0022-3476(97)70235-x.
3
Biochemical and in vivo properties of commercial virus-inactivated factor VIII concentrates.市售病毒灭活凝血因子VIII浓缩物的生化特性及体内特性
Eur J Haematol. 1988 Mar;40(3):205-14. doi: 10.1111/j.1600-0609.1988.tb00825.x.
4
In vivo recovery and survival of monoclonal-antibody-purified factor VIII concentrates.单克隆抗体纯化的凝血因子 VIII 浓缩物的体内回收率和存活率。
Thromb Haemost. 1991 Dec 2;66(6):730-3.
5
Pharmacokinetic properties of recombinant factor VIII compared with a monoclonally purified concentrate (Hemofil M). The Recombinate Study Group.
Thromb Haemost. 1992 Oct 5;68(4):433-5.
6
Treatment of hemophilia A with a highly purified factor VIII concentrate prepared by anti-FVIIIc immunoaffinity chromatography.采用抗FVIIIc免疫亲和层析法制备的高纯度凝血因子VIII浓缩物治疗甲型血友病。
Thromb Haemost. 1992 Jan 23;67(1):19-27.
7
In vivo recovery of factor VIII: a comparison of one-stage and two-stage assay methods.体内因子VIII的回收率:单阶段和双阶段测定方法的比较。
Thromb Haemost. 1979 Dec 21;42(4):1230-9.
8
Successful preoperative apheresis of factor VIII antibody using factor VIII concentrate as a replacement fluid.使用凝血因子 VIII 浓缩物作为置换液成功进行术前凝血因子 VIII 抗体去除术。
J Clin Apher. 1986;3(2):140. doi: 10.1002/jca.2920030212.
9
Factor VIII procoagulant antigen recovery is a dose-related response to Factor VIII concentrate infusions.凝血因子 VIII 促凝抗原回收率是对凝血因子 VIII 浓缩剂输注的剂量相关反应。
Haemostasis. 1984;14(4):296-301. doi: 10.1159/000215078.
10
Incidence of factor VIII inhibitor development in severe hemophilia A patients treated only with one brand of highly purified plasma-derived concentrate.
Thromb Haemost. 1995 Feb;73(2):215-8.